SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-204703
Filing Date
2020-07-30
Accepted
2020-07-30 20:16:47
Documents
1
Group Members
FHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.JAMES TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D d41550dsc13da.htm SC 13D/A 102814
  Complete submission text file 0001193125-20-204703.txt   104674
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88896 | Film No.: 201062940
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences VIII, L.P. (Filed by) CIK: 0001655827 (see all company filings)

IRS No.: 475290848 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A